SLC22A4 and cancer: Based on our results, OCTN1 could be hypothesized as a novel target for drugs that may impair the NNCS in cancers in which this system is important for proliferation and EMT (Wu et al., 2022; Sales et al., 2019; Zhao et al., 2015).